Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Global position paper on cardiovascular regenerative medicine.
Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee; Translational Research Subcommittee; Challenges of Cardiovascular Regenerative Medicine Subcommittee; Tissue Engineering Subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee; Clinical Trials Subcommittee; Regulatory and funding strategies subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee. Fernández-Avilés F, et al. Among authors: kim hs. Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248. Eur Heart J. 2017. PMID: 28575280 Free PMC article. Review. No abstract available.
Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
Han JK, Kim HL, Jeon KH, Choi YE, Lee HS, Kwon YW, Jang JJ, Cho HJ, Kang HJ, Oh BH, Park YB, Kim HS. Han JK, et al. Among authors: kim hl, kim hs. Eur Heart J. 2013 Jun;34(23):1755-65. doi: 10.1093/eurheartj/ehr365. Epub 2011 Sep 14. Eur Heart J. 2013. PMID: 21920965
Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors.
Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kim HS, Valgimigli M, Palmerini T, Stone GW. Lee SY, et al. Among authors: kim js, kim bk, kim hs. Clin Res Cardiol. 2017 Mar;106(3):165-173. doi: 10.1007/s00392-016-1035-4. Epub 2016 Sep 8. Clin Res Cardiol. 2017. PMID: 27631821 Free article. Clinical Trial.
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
Palmerini T, Della Riva D, Benedetto U, Bacchi Reggiani L, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Sangiorgi D, Biondi-Zoccai G, Généreux P, Angelini GD, Pufulete M, White J, Bhatt DL, Stone GW. Palmerini T, et al. Among authors: kim bk, kim hs. Eur Heart J. 2017 Apr 7;38(14):1034-1043. doi: 10.1093/eurheartj/ehw627. Eur Heart J. 2017. PMID: 28110296 Free PMC article. Review.
Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.
Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group. Fernández-Avilés F, et al. Among authors: kim hs. Circ Res. 2018 Jan 19;122(2):199-201. doi: 10.1161/CIRCRESAHA.117.312099. Circ Res. 2018. PMID: 29348246 No abstract available.
A prominent coronary Thebesian system.
Park KW, Kim YJ, Kim HS. Park KW, et al. Among authors: kim yj, kim hs. Eur Heart J. 2007 Oct;28(20):2448. doi: 10.1093/eurheartj/ehm190. Epub 2007 Jun 3. Eur Heart J. 2007. PMID: 17548340 No abstract available.
N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS. Jo SH, et al. Among authors: kim yj, kim hl, kim hs. Am Heart J. 2009 Mar;157(3):576-83. doi: 10.1016/j.ahj.2008.11.010. Epub 2009 Feb 6. Am Heart J. 2009. PMID: 19249432 Clinical Trial.
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial.
Park KW, Park JJ, Lee SP, Oh IY, Suh JW, Yang HM, Lee HY, Kang HJ, Cho YS, Koo BK, Youn TJ, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Park KW, et al. Among authors: kim hs. Heart. 2011 Apr;97(8):641-7. doi: 10.1136/hrt.2010.216499. Epub 2011 Feb 22. Heart. 2011. PMID: 21345843 Clinical Trial.
15,689 results
You have reached the last available page of results. Please see the User Guide for more information.